Search filters

List of works by Elke Pogge von Strandmann

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

scientific journal article

A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

scientific article published on 6 October 2005

A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma

scientific article published on 17 April 2015

ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro

scientific article published on January 2007

Antigen Loss Variants: Catching Hold of Escaping Foes

scientific article published on 24 February 2017

Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma

scientific article published on 8 December 2012

CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro

scientific article published on 20 April 2016

Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids

scientific article

Combination of the human anti-CD30 antibody 5F11 with cytostatic drugs enhances its antitumor activity against Hodgkin and anaplastic large cell lymphoma cell lines

scientific article published on September 2004

DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies

scientific article published on 4 February 2015

Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor

scientific article

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.

scientific article published on 12 August 2015

Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function

scientific journal article

Depletion of cellular cholesterol and lipid rafts increases shedding of CD30.

scientific article published on April 2004

Effects of the anti-VEGF monoclonal antibody bevacizumab in a preclinical model and in patients with refractory and multiple relapsed Hodgkin lymphoma.

scientific article published in June 2009

Evidence of Inbreeding in Hodgkin Lymphoma

scientific article

Extracellular vesicles released from chronic lymphocytic leukemia cells exhibit a disease relevant mRNA signature and transfer mRNA to bystander cells

scientific article published on 17 November 2016

Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma

scientific article published on 26 February 2013

Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity

scientific article published on 11 August 2009

Heritability estimates on Hodgkin's lymphoma: a genomic- versus population-based approach

scientific article published on 17 September 2014

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells

scientific article

Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma

scientific article published on 27 April 2011

Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitro

scientific article published on October 2013

Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity

scientific article published on 13 June 2017

Mechanisms of Tumor and Viral Immune Escape from Natural Killer Cell-Mediated Surveillance ⬇️

scientific article published on May 11, 2011

Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.

scientific article published on 29 April 2014

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

scientific article published on 23 November 2018

Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia

scientific article published on 15 July 2016

NKp30 and its ligands: emerging players in tumor immune evasion from natural killer cells

scientific article published in November 2015

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

scientific article published on 10 May 2017

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

scientific article published on 25 April 2016

Natural ligands and antibody-based fusion proteins: harnessing the immune system against cancer

scientific article

Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma

scientific article

RIG-I activation induces the release of extracellular vesicles with antitumor activity

scientific article published on 19 August 2016

Regulation of self-ligands for activating natural killer cell receptors

scientific article published on 23 May 2013

Rescue of impaired NK cell activity in hodgkin lymphoma with bispecific antibodies in vitro and in patients

scientific article published on 5 March 2013

Role of Exosomes Released by Dendritic Cells and/or by Tumor Targets: Regulation of NK Cell Plasticity

scientific article published on 07 March 2014

Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation

scientific article

Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity

scientific article published on 18 March 2013

The Unique Molecular and Cellular Microenvironment of Ovarian Cancer

scientific article published on 22 February 2017

The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma

scientific article published on 29 November 2013

The fully human anti-CD30 antibody 5F11 activates NF-{kappa}B and sensitizes lymphoma cells to bortezomib-induced apoptosis

scientific article

The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines

scientific article

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

scientific article published on 8 September 2017

Tumor-Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure

scientific article

Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma

scientific journal article

Paulina is supported by:

About Paulina

Help